Oldest pages

Showing below up to 50 results in range #1 to #50.

1. 5-FU + Cisplatin‏‎ (02:17, 7 February 2012)
2. 5-FU + Cisplatin + Docetaxel‏‎ (02:17, 7 February 2012)
3. 5-FU + Cisplatin + RT‏‎ (02:17, 7 February 2012)
4. 5-FU + Cisplatin + RT + Surgery‏‎ (02:17, 7 February 2012)
5. 5-FU + Cisplatin + Vinblastine + RT + Surgery‏‎ (02:17, 7 February 2012)
6. 5-FU + RT‏‎ (02:17, 7 February 2012)
7. AIDA-PETHEMA Group‏‎ (02:17, 7 February 2012)
8. 5-FU MitomycinC Radiation Therapy EORTC Regimen‏‎ (02:17, 7 February 2012)
9. ASHAP‏‎ (02:17, 7 February 2012)
10. 5-FU MitomycinC Radiation Therapy Wayne State Regimen‏‎ (02:17, 7 February 2012)
11. A-C-T‏‎ (02:17, 7 February 2012)
12. Acute Lymphoblastic Leukemia, Adult‏‎ (02:17, 7 February 2012)
13. ABDIC‏‎ (02:17, 7 February 2012)
14. Acute Lymphoblastic Leukemia, Pediatric‏‎ (02:17, 7 February 2012)
15. ABVD‏‎ (02:17, 7 February 2012)
16. 5-FU + LV‏‎ (02:17, 7 February 2012)
17. AC‏‎ (02:17, 7 February 2012)
18. Adriamycin + Cisplatin‏‎ (02:17, 7 February 2012)
19. 5-FU + LV + Bevacizumab‏‎ (02:17, 7 February 2012)
20. AD‏‎ (02:17, 7 February 2012)
21. Adriamycin + Cisplatin + Paclitaxel‏‎ (02:17, 7 February 2012)
22. 5-FU + LV + Irinotecan‏‎ (02:17, 7 February 2012)
23. ADE‏‎ (02:17, 7 February 2012)
24. Alemtuzumab‏‎ (02:17, 7 February 2012)
25. 5-FU + LV + Mitomycin + Dipyridamole‏‎ (02:17, 7 February 2012)
26. ADOC‏‎ (02:17, 7 February 2012)
27. 5-FU + LV + RT‏‎ (02:17, 7 February 2012)
28. AI‏‎ (02:17, 7 February 2012)
29. Amrubicin‏‎ (02:17, 7 February 2012)
30. Bevacizumab + Erlotinib‏‎ (02:17, 7 February 2012)
31. CALGB 8811‏‎ (02:17, 7 February 2012)
32. Anal Carcinoma‏‎ (02:17, 7 February 2012)
33. Bevacizumab + IFN‏‎ (02:17, 7 February 2012)
34. Arsenic Trioxide for APML, new cases‏‎ (02:17, 7 February 2012)
35. BiRD‏‎ (02:17, 7 February 2012)
36. Arsenic Trioxide for relapsed APML‏‎ (02:17, 7 February 2012)
37. Bicalutamide‏‎ (02:17, 7 February 2012)
38. Azacitidine‏‎ (02:17, 7 February 2012)
39. Bile Duct Cancer Extrahepatic‏‎ (02:17, 7 February 2012)
40. BEP‏‎ (02:17, 7 February 2012)
41. Bladder Cancer‏‎ (02:17, 7 February 2012)
42. BFM- 95 (German Protocol)‏‎ (02:17, 7 February 2012)
43. Bonn protocol‏‎ (02:17, 7 February 2012)
44. BFM B-Cell‏‎ (02:17, 7 February 2012)
45. Bortezomib‏‎ (02:17, 7 February 2012)
46. Bendamustine‏‎ (02:17, 7 February 2012)
47. Brain Tumors Adult‏‎ (02:17, 7 February 2012)
48. Bendamustine + Rituximab‏‎ (02:17, 7 February 2012)
49. Breast Cancer‏‎ (02:17, 7 February 2012)
50. Alemtuzumab + Fludarabine‏‎ (02:17, 7 February 2012)